FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria

被引:62
|
作者
Sun, Hongcheng [1 ]
Teng, Mujian [2 ]
Liu, Jie [2 ]
Jin, Dong [3 ]
Wu, Junyi [1 ]
Yan, Dongwang [1 ]
Fan, Junwei [1 ]
Qin, Xuebin [4 ]
Tang, Huamei [5 ]
Peng, Zhihai [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Affiliated Peoples Hosp 1, Dept Gen Surg, Shanghai 200080, Peoples R China
[2] Shangdong Univ, Affiliated Qianfoshan Hosp, Dept Hepatobiliary & Pancreat Surg, Jinan 250014, Shandong, Peoples R China
[3] Ningxia Med Univ, Affiliated Hosp, Dept Hepatobiliary Surg, Yinchuan 750004, Ningxia Prov, Peoples R China
[4] Brigham & Womens Hosp, Dept Medicine, Boston, MA 02139 USA
[5] Shanghai Jiao Tong Univ, Sch Med, Affiliated Peoples Hosp 1, Dept Pathol, Shanghai 200080, Peoples R China
关键词
Hepatocellular carcinoma; Orthotopic liver transplantation; FOXM1; Biomarker; TRANSCRIPTION FACTOR; EXPANSION; INVASION; IMPACT;
D O I
10.1016/j.canlet.2011.03.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Molecular biomarker has been proposed to improve patient selection and post-transplant prognostication, but rare achievement has been made. In the present study, Forkhead box M1 (FOXM1) expression and its prognostic role have been investigated in hepatocellular carcinoma (HCC) treated by orthotopic liver transplantation (OLT). We found that the notably higher level of FOXM1 in tumors was associated with malignant pathological features of HCC and unfavorable outcome after OLT. The status of FOXM1 expression combined with the Milan criteria could make the prognostication more accurate and may be of particular interest for expanding the criteria in selecting transplant candidates. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:214 / 222
页数:9
相关论文
共 50 条
  • [41] Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
    Beumer, Berend
    van Vugt, Jeroen
    Sapisochin, Gonzalo
    Yoon, Peter
    Bongini, Marco
    Lu, Di
    Xu, Xiao
    De Simone, Paolo
    Pintore, Lorenzo
    Golse, Nicolas
    Nowosad, Malgorzata
    Bennet, William
    Tsochatzis, Emmanuel
    Koutli, Evaggelia
    Abbassi, Fariba
    Claasen, Marco
    Merli, Manuela
    Orourke, Joanne
    Gambato, Martina
    Benito, Alberto
    Majumdar, Avik
    Tan, Ek Khoon
    Ebadi, Maryam
    Montano-Loza, Aldo J.
    Berenguer, Marina
    Metselaar, Herold
    Polak, Wojciech
    Mazzaferro, Vincenzo
    Ijzermans, Jan
    JOURNAL OF HEPATOLOGY, 2022, 77 : S815 - S817
  • [42] Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Xu, Xiao
    Lu, Di
    Ling, Qi
    Wei, Xuyong
    Wu, Jian
    Zhou, Lin
    Yan, Sheng
    Wu, Liming
    Geng, Lei
    Ke, Qinghong
    Gao, Feng
    Tu, Zhenhua
    Wang, Weilin
    Zhang, Min
    Shen, Yan
    Xie, Haiyang
    Jiang, Weishi
    Wang, Haibo
    Zheng, Shusen
    LIVER TRANSPLANTATION, 2014, 20 : S113 - S113
  • [43] Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
    Beumer, Berend R.
    van Vugt, Jeroen L. A.
    Sapisochin, Gonzalo
    Yoon, Peter
    Bongini, Marco
    Lu, Di
    Xu, Xiao
    De Simone, Paolo
    Pintore, Lorenzo
    Golse, Nicolas
    Nowosad, Malgosia
    Bennet, William
    Tsochatzis, Emmanouil
    Koutli, Evangelia
    Abbassi, Fariba
    Claasen, Marco P. A. W.
    Merli, Manuela
    O'Rourke, Joanne
    Gambato, Martina
    Benito, Alberto
    Majumdar, Avik
    Tan, Ek Khoon
    Ebadi, Maryam
    Montano-Loza, Aldo J.
    Berenguer, Marina
    Metselaar, Herold J.
    Polak, Wojciech G.
    Mazzaferro, Vincenzo
    IJzermans, Jan N. M.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (05) : 2373 - 2382
  • [44] Milan criteria and its expansions in liver transplantation for hepatocellular carcinoma
    Zhu, Zhijun
    HEPATOBILIARY SURGERY AND NUTRITION, 2016, 5 (06) : 498 - 502
  • [45] Combinations of Biomarkers and Milan Criteria for Predicting Hepatocellular Carcinoma Recurrence After Liver Transplantation
    Chaiteerakij, Roongruedee
    Zhang, Xiaodan
    Addissie, Benyam D.
    Mohamed, Essa A.
    Harmsen, William S.
    Theobald, Paul J.
    Peters, Brian E.
    Balsanek, Joseph G.
    Ward, Melissa M.
    Giama, Nasra H.
    Moser, Catherine D.
    Oseini, Abdul M.
    Umeda, Naoki
    Venkatesh, Sudhakar
    Harnois, Denise M.
    Charlton, Michael R.
    Yamada, Hiroyuki
    Satomura, Shinji
    Algeciras-Schimnich, Alicia
    Snyder, Melissa R.
    Therneau, Terry M.
    Roberts, Lewis R.
    LIVER TRANSPLANTATION, 2015, 21 (05) : 599 - 606
  • [46] Survival in Patients with Hepatocellular Carcinoma within Milan Criteria Treated with Locoregional Therapies after Orthotopic Liver Transplant Denial
    Villanueva, Faith
    Hatamleh, Diana
    Zori, Andreas
    Forde, Justin
    Mota, Manoela
    Ismael, Media
    Johnson, Lindsey
    Cabrera, Roniel
    HEPATOLOGY, 2018, 68 : 547A - 548A
  • [47] Predictors of outcome after liver transplantation for hepatocellular carcinoma (HCC) beyond Milan criteria
    Halazun, K. J.
    Sapisochin, G.
    von Ahrens, D.
    Agopian, V. G.
    Tabrizian, P.
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 82 : 61 - 69
  • [48] Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
    Xiao, Guang-Qin
    Liu, Chang
    Liu, Da-Li
    Yang, Jia-Yin
    Yan, Lu-Nan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (45) : 8398 - 8407
  • [49] Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
    Guang-Qin Xiao
    Chang Liu
    Da-Li Liu
    Jia-Yin Yang
    Lu-Nan Yan
    World Journal of Gastroenterology, 2013, (45) : 8398 - 8407
  • [50] Stick to Milan: Infeasibility of the Brazil-Milan Criteria in recommending patients with hepatocellular carcinoma for liver transplantation
    Ng, Alexander Clevewood
    ANNALS OF HEPATOLOGY, 2021, 25